Mirjam-Collete Kempf, Ph.D., M.P.H., and Michael Saag, M.D., received a $3 million, five-year award to join the Women’s Interagency HIV study (WIHS). Saag is serving as principal investigator at UAB and a sister site at the University of Mississippi Medical Center, and Kempf is co-principal investigator. Recruitment begins at UAB this October. The WIHS is a longitudinal study that examines how HIV affects the health of women; it is also the longest running study funded by the National Institutes of Health (NIH) for women's health and HIV.
Established in 1993, the WIHS cohort originally had no representation from southern states, despite the heavy HIV disease burdens in the South. Recognizing the need, the NIH approved bringing the study to UAB and its sister site in Jackson, Miss.; Chapel Hill, N.C.; Atlanta, Ga.; and Miami, Fla.
“WIHS is one of the premiere HIV cohorts in the country, and we are very pleased to be a part of it,” said Saag.
For UAB’s cohort, 100 women between the ages 25-60 years old will be needed; 75 of those HIV-positive. Study enrollment will take place at the 1917 Clinic.
Call for proposals: Explore research for palliative careThe Palliative Research Enhancement Project invites research proposals for innovative translational and/or clinical research projects that use palliative medicine.UAB awarded $9.7 million to find treatments for deadly lung diseaseGrant will allow UAB researchers to study novel therapies for pulmonary fibrosis, a deadly lung disease with no approved treatments.UAB vision scientist awarded $1.81 million grant for photoreceptor researchLawrence Sincich, Ph.D., received a $1.81 million NIH National Eye Institute award for work that will lead to better understanding of color perception in the brain.Grant renewal extends, expands national research of kidney failureWorld-renowned scientists search for ways to prevent acute kidney failure, improve management of the disease.National women’s HIV study comes to UABStudy examines how HIV affects the health of women.UAB, BBA partner to win prestigious $600,000 NSF Partnership for Innovation grantThe NSF will support a UAB/BBA collaboration through a $600,000 award — the first Partnership for Innovation grant ever given in Alabama.UAB DRC awarded grant, recruiting for national studyUAB investigators are studying the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. Recruitment of volunteers for the project, called the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study, begins in June.UAB and School of Dentistry ranked first nationally in NIDCR fundingThe UAB School of Dentistry received more funding from the National Institutes of Health in 2012 than any other school of dentistry in the nation.UAB glaucoma researchers to study biomechanics of eyeThe primary investigators are examining whether age- and race-related differences in the biomechanics of the optic nerve head may contribute to this risk.UAB Diabetes Research Center receives 5 year grant exceeding $5 millionThe Diabetes Research Center (DRC) focuses on developing new methods to treat, prevent and ultimately cure diabetes and its complications.